Keenova Therapeutics plc Operating Lease Right-of-Use Assets
Keenova Therapeutics plc had Operating Lease Right-of-Use Assets of $59.20 million as of 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-04-15
- 2025-12-31: Operating Lease, Right-of-Use Asset $59.20M.
- 2024-12-27: Operating Lease, Right-of-Use Asset $23.10M; Operating Lease, Right-of-Use Asset as first filed $56.30M.
- 2023-12-29: Operating Lease, Right-of-Use Asset $50.90M.
- 2022-12-30: Operating Lease, Right-of-Use Asset $38.10M.
| Period end | Operating Lease, Right-of-Use Asset | Operating Lease, Right-of-Use Asset as first filed |
|---|---|---|
| 2025-12-31 | $59.20M 10-K · filed 2026-04-15 | |
| 2024-12-27 | $23.10M 10-K · filed 2026-04-15 | $56.30M 10-K · filed 2025-03-13 |
| 2023-12-29 | $50.90M 10-K · filed 2025-03-13 | |
| 2022-12-30 | $38.10M 10-K · filed 2024-03-26 | |
| 2021-12-31 | $35.00M 10-K · filed 2023-03-03 | |
| 2020-12-25 | $58.60M 10-K · filed 2022-03-15 | |
| 2019-12-27 | $83.50M 10-K · filed 2021-03-10 | |
| 2019-09-27 | $84.70M 10-Q · filed 2019-11-05 | |
| 2019-06-28 | $90.60M 10-Q · filed 2019-08-06 | |
| 2019-03-29 | $80.80M 10-Q · filed 2019-05-07 |